Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04374305
Title Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) (INTUITT-NF2)
Acronym INTUITT-NF2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Scott R. Plotkin, MD, PhD
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.